Peptides in clinical development for the treatment of brain tumors

Giulia Guidotti, Liliana Brambilla, Daniela Rossi

Research output: Contribution to journalReview articlepeer-review


Peptides have emerged as novel and promising medicaments for the treatment of many human diseases, including tumors. In the treatment of cancer, they can be employed directly as bioactive therapeutics, promoting the reduction of tumor growth, but also as drug delivery systems, to facilitate the passage of drugs through cell and tissue barriers and to increase the selectivity of therapeutics for tumor cells. The advantages of peptides over standard chemotherapeutic agents are several-fold and include ease of synthesis, high efficacy, reduced side-effects, and low production cost. Numerous preclinical evaluations with different types of peptides have provided promising results in murine brain tumor models. Some of the most effective molecules were translated into clinical trials, opening new perspectives for the treatment of high-grade brain tumors and metastases.

Original languageEnglish
Pages (from-to)102-109
Number of pages8
JournalCurrent Opinion in Pharmacology
Publication statusPublished - Aug 2019

Fingerprint Dive into the research topics of 'Peptides in clinical development for the treatment of brain tumors'. Together they form a unique fingerprint.

Cite this